In a promising development for diabetes treatment,
researchers have developed a network of nanoscale particles that can be injected
into the body and release insulin when blood-sugar levels rise, maintaining
normal blood sugar levels for more than a week in animal-based laboratory
tests. The work was done by researchers at North Carolina State University, the
University of North Carolina at Chapel Hill, the Massachusetts Institute of
Technology and Children’s Hospital Boston.